- Home
- ACN vs NVS Comparison
ACN vs NVS Comparison
Compare ACN & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACN
- NVS
- Stock Information
- Founded
- ACN 1989
- NVS 1895
- Country
- ACN Ireland
- NVS Switzerland
- Employees
- ACN N/A
- NVS N/A
- Industry
- ACN Business Services
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- ACN Consumer Discretionary
- NVS Health Care
- Exchange
- ACN Nasdaq
- NVS Nasdaq
- Market Cap
- ACN 209.2B
- NVS 230.5B
- IPO Year
- ACN N/A
- NVS 1991
- Fundamental
- Price
- ACN $358.55
- NVS $104.29
- Analyst Decision
- ACN Buy
- NVS Hold
- Analyst Count
- ACN 20
- NVS 6
- Target Price
- ACN $369.85
- NVS $121.25
- AVG Volume (30 Days)
- ACN 2.6M
- NVS 1.4M
- Earning Date
- ACN 12-19-2024
- NVS 10-29-2024
- Dividend Yield
- ACN 1.65%
- NVS 3.63%
- EPS Growth
- ACN 6.16
- NVS 130.53
- EPS
- ACN 11.44
- NVS 8.58
- Revenue
- ACN $64,896,464,000.00
- NVS $49,940,000,000.00
- Revenue This Year
- ACN $7.81
- NVS $10.04
- Revenue Next Year
- ACN $6.84
- NVS $4.55
- P/E Ratio
- ACN $31.37
- NVS $11.74
- Revenue Growth
- ACN 1.22
- NVS 8.92
- 52 Week Low
- ACN $278.69
- NVS $92.35
- 52 Week High
- ACN $387.51
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- ACN 51.11
- NVS 32.83
- Support Level
- ACN $349.99
- NVS $102.40
- Resistance Level
- ACN $372.00
- NVS $103.42
- Average True Range (ATR)
- ACN 6.71
- NVS 0.92
- MACD
- ACN 0.07
- NVS -0.00
- Stochastic Oscillator
- ACN 54.85
- NVS 26.81
About ACN Accenture plc (Ireland)
Accenture is a leading global IT-services firm that provides consulting, strategy, and technology and operational services. These services run the gamut from aiding enterprises with digital transformation to procurement services to software system integration. The company provides its IT offerings to a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture employs just under 500,000 people throughout 200 cities in 51 countries.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.